Read + Share
Amedeo Smart
Independent Medical Education
Xu J, Gao Y, Luan X, Li K, et al. An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer. Cancer Chemother Pharmacol 2022 Apr 13. pii: 10.1007/s00280-022-04403.PMID: 35419627
Email
LinkedIn
Facebook
Twitter
Privacy Policy